|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| Pharmaceutical Pricing Strategies 2000: Entering the new millennium |
|
|
|
|
€ 955,00 |
Editeur
: |
Business Insight |
Langue
: |
Anglais |
Date de publication : |
Juin 2000 |
Taille du document : |
240 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (5) |
|
|
|
| 52 pages | Août 2004 | Anglais
|
|
|
| Main
focus: |
healthcare,health care,life sciences,hospital,...
|
| Research
focus: |
industry structure,market size and estimates, |
| Geographic
focus: |
usa,mauritius,france,india |
| |
|
|
|
|
| 46 pages | Septembre 2000 | Anglais
|
|
|
| Main
focus: |
healthcare,health care,dentists,private healthcare
|
| Research
focus: |
market size and estimates,market segmentation, |
| Geographic
focus: |
united kingdom,usa,japan,philippines,germany,... |
| |
|
|
|
|
| 78 pages | Janvier 2005 | Anglais
|
|
|
| Main
focus: |
healthcare,health care,healthcare informatics,...,...
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,canada,united kingdom,australia |
| |
|
|
|
|
| 52 pages | Janvier 2007 | Anglais
|
|
|
| Main
focus: |
healthcare,health care,healthcare informatics,...
|
| Research
focus: |
market size and estimates,industry structure, |
| Geographic
focus: |
usa,france,united kingdom,canada,australia,china |
| |
|
|
|
|
| 84 pages | Mars 2005 | Anglais
|
|
|
| Main
focus: |
healthcare,health care,dentists,life sciences,...
|
| Research
focus: |
demand analysis,competition analysis, |
| Geographic
focus: |
usa,mexico,india,united kingdom |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
The Drug Discovery Outlook: Drivers of innovation in the 21st Century
189 pages | Octobre 2000 |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century introduces and analyzes the five key enabling technologies and bioinformatics, which are currently driving pharmaceutical dru |
955,00 €
|
| |
| |
Pharmaceutical Packaging Market
80 pages | Avril 2002 |
This report will enable you to:Analyse the size of the UK market for pharmaceutical packaging between 1997 and 2006, by type: - cartons - containers - labels and leaflets - blister & strip p |
1 479,00 €
|
| |
| |
Chinese Markets for OTC Drugs
220 pages | Février 2002 |
China's demand for OTC drugs has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's economic trend |
3 500,00 €
|
| |
| |
The Generics Outlook 2001
242 pages | Février 2001 |
“By the year 2004, it is expected that the value of the total western European generics sector may have risen to $19 billion, representing almost 15% of allpharmaceuticals.
In the USA, the val |
955,00 €
|
| |
| |
Healthcare In Southern Ireland
40 pages | Mai 2000 |
The Republic Of Ireland Presentation Includes:- The Structure Of The Health Service In The Republic Of Ireland- Capital Expenditure On Health Care In The Republic Of Ireland- Number Of Publicly Funded |
327,00 €
|
| |
| |
Generic Pharmaceutical Outlook 1998-2008
190 pages | Octobre 1998 |
Currently estimated to account for approximately 11% of Global pharmaceutical sales, this figure looks set to rise dramatically as branded drugs come off-patent within the next decade.
Imminent |
795,00 €
|
| |
| |
OTC Analgesics in Germany
15 pages | Juillet 2002 |
The German market for OTC analgesics growth not so rapidly and reached a value of Euro 772 million (US$ 729 million) in 2001, an increase of 1.6% on the previous year.
Over the review period, the m |
198,00 €
|
| |
| |
Healthcare: Germany
106 pages | Octobre 2000 |
Compare the changes in expenditure between the different healthcare sectors in Germany · Understand the main factors affecting demand for healthcare services in Germany · Examine the |
578,54 €
|
| |
| |
Pharmaceutical Mergers & Aquisitions: the third wave
160 pages | Février 1999 |
Historical assessment : The report identifies the factors that have driven the two historical waves of M&A activity, and analyses the relative importance of these factors through case studies.
795,00 €
|
|
| |
| |
OTC Cough and Cold Remedies in Germany
15 pages | Juillet 2002 |
The German market for OTC cough and cold remedies reached a value of Euro 972 million (US$ 918 million) in 2001, up 0.4% on the previous year.
During the review period, the market grew by 9.4%, an |
198,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Pharmaceutical Pricing Strategies 2000: Entering the new millennium |
|
|
The favorable climate of the pharmaceutical sector has changed radically over
the past ten years.
Where once a company's freedom over pricing decisions was almost limitless,
external pressures such as costcontainment now restrict the industry's revenue
opportunities.
Therefore, the pressure on pharmaceutical companies to develop new strategies
to maintain and justify the premium pricing of a product is immense.
Consequently, it is more vital than ever before that players truly understand
the changing healthcare landscape.
Pharmaceutical Pricing Strategies 2000 draws upon extensive primary
research from industry executives and regulatory bodies to provide the answers
to current and future pricing issues.
The report details the changes in pricing regulations in each of the seven major
healthcare markets and offers novel analysis as to how they influence the pricing
decisions of pharmaceutical players.
This strategic management report will enable you to make informed decisions
about your companies strategic direction in the increasingly competitive healthcare
arena.
The changing face of pharmaceutical pricing :
This section identifies, analyzes and assesses the historic impact that cost-containment
has had on the previously unrestricted healthcare arena.
Definitions, methods, objectives and strategies :
This section gives detailed definitions of both the function and role of pricing
while analyzing the underlying economic principles that govern its application.
Country specific pricing issues :
These sections contain a comprehensive analysis of the local healthcare system
and pricing regulations in the three major regional markets of the US, Japan
and the EU (including Germany, France, the UK, Italy and Spain).
Pricing differentials :
This section contains a comprehensive analysis of pharmaceutical pricing differentials;
detailing the impact that these differentials can have on the revenue opportunities
of pharmaceutical companies.
Pricing strategies for 2000 :
The final section of the report assesses the direction of future pricing strategies.
It analyzes the drivers that are likely to reshape the healthcare environment
from the increasing power of the patient to the emergence of pharmacoeconomic
studies.
|
|
Chapter 1: The changing pharmaceutical pricing climate
Chapter 2: Pricing definitions, methods, objectives and strategies
Chapter 3: Pricing in the US
Chapter 4: Pricing in Japan
Chapter 5: Pricing in the EU
Chapter 6: Pricing differentials
Chapter 7: The future of pharmaceutical pricing strategies
Chapter 8: Appendix
|
|
|
PPLSEN
|
|
|
|
|
